17-47809393-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_145798.3(OSBPL7):c.1966G>A(p.Glu656Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 32)
Consequence
OSBPL7
NM_145798.3 missense
NM_145798.3 missense
Scores
5
10
4
Clinical Significance
Conservation
PhyloP100: 7.90
Genes affected
OSBPL7 (HGNC:16387): (oxysterol binding protein like 7) This gene encodes a member of the oxysterol-binding protein (OSBP) family, a group of intracellular lipid receptors. Like most members, the encoded protein contains an N-terminal pleckstrin homology domain and a highly conserved C-terminal OSBP-like sterol-binding domain. Two transcript variants encoding the same isoform have been identified. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.77
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OSBPL7 | NM_145798.3 | c.1966G>A | p.Glu656Lys | missense_variant | 19/23 | ENST00000007414.8 | |
OSBPL7 | XM_047435292.1 | c.1966G>A | p.Glu656Lys | missense_variant | 19/23 | ||
OSBPL7 | XM_047435293.1 | c.1912G>A | p.Glu638Lys | missense_variant | 18/22 | ||
OSBPL7 | XR_934362.2 | n.2182G>A | non_coding_transcript_exon_variant | 19/22 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OSBPL7 | ENST00000007414.8 | c.1966G>A | p.Glu656Lys | missense_variant | 19/23 | 1 | NM_145798.3 | P1 | |
OSBPL7 | ENST00000613735.4 | c.*246-278G>A | intron_variant, NMD_transcript_variant | 1 | |||||
OSBPL7 | ENST00000583167.5 | n.3016G>A | non_coding_transcript_exon_variant | 7/11 | 2 | ||||
OSBPL7 | ENST00000579728.5 | c.*781G>A | 3_prime_UTR_variant, NMD_transcript_variant | 18/22 | 5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 34
GnomAD4 exome
Cov.:
34
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 12, 2022 | The c.1966G>A (p.E656K) alteration is located in exon 19 (coding exon 18) of the OSBPL7 gene. This alteration results from a G to A substitution at nucleotide position 1966, causing the glutamic acid (E) at amino acid position 656 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;T
Eigen
Uncertain
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
.;D
M_CAP
Benign
D
MetaRNN
Pathogenic
D;D
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D
REVEL
Uncertain
Sift
Uncertain
D;D
Sift4G
Uncertain
D;D
Polyphen
D;D
Vest4
MutPred
Gain of MoRF binding (P = 0.0167);Gain of MoRF binding (P = 0.0167);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at